Pseudohyponatremia of Multiple Myeloma is True Hyponatremia

Hyponatremia of Multiple Myeloma Clinical Trial

Official title:

a Study to Evaluate the Electrolyte Changes in Particular Sodium,in Multiple Myeloma and the Effect of the m- Proteins on the Strong Ion Difference

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01425606
• Other study ID #: 039-2011
• Status: Not yet recruiting
• Phase: Phase 4
• First received: June 9, 2011
• Last updated: August 28, 2011
• Start date: September 2011
• Est. completion date: June 2012

Study information

• Verified date: August 2011
• Source: Meir Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Observational

Clinical Trial Summary

Hypothesis: the hyponatremia of multiple myeloma (m.m.)is true and not pseudohyponatremia by using the stewart approach to acid - base interpretation, would like to show that the positive charged m- proteins produced in m.m.result in true hyponatremia.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: June 2012
• Est. primary completion date: June 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients with multiple myeloma

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hyponatremia
• Hyponatremia of Multiple Myeloma
• Multiple Myeloma
• Neoplasms, Plasma Cell

Intervention

Other:
• blood test
blood test to measure levels of: sodium, albumin and acid - base status in venous blood.

Locations

Country	Name	City	State
Israel	Meir Hospital	Kfar Saba

Sponsors (1)

Lead Sponsor	Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	hyponatremia present or not		one year	No
Primary	hyponatremia	pseoudohyponatremia or not	one year	No